Publications by authors named "P Seksik"

Claim this Profile
F
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.
Aurélien Amiot, Julien Kirchgesner, Hadrien Alric, Xavier Tréton, Mathieu Uzzan, Philippe Seksik

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease.
Zlata Chkolnaia, Benedicte Lebrun-Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard, Philippe Seksik

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPACT OF ENDOMETRIOSIS ON THE PROGRESSION OF INFLAMMATORY BOWEL DISEASES: A MULTICENTER RETROSPECTIVE STUDY.
Lucas Guillo, Oumaya El Oumami, Philippe Seksik, Guillaume Le Cosquer, Louise Méheut

Clin Transl Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.
Lucile Fontaine, Philippe Seksik, Carmen Stefanescu, Maria Nachury, Stéphane Nancey

Dig Liver Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UC.
Anaïs Bertrand, Antoine Meyer, Julien Kirchgesner, Mathieu Uzzan, Vered Abitbol, Philippe Seksik

Clin Res Hepatol Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis